How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

76,785 results for

Cancer Prevention

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Cancer league actions against sunbed use for skin cancer prevention. (PubMed)

Cancer league actions against sunbed use for skin cancer prevention. The incidence of non-melanoma and melanoma skin cancer has been rising in Europe. Although the World Health Organization's International Agency for Research on Cancer has since 2009 classified sunbeds as a Group 1 carcinogen, sunbed use, especially by those under the age of 18, continues to be a concern. As the only platform for cancer leagues in Europe, the Association of European Cancer Leagues decided to explore interest

2019 Journal of the European Academy of Dermatology and Venereology

62. Standardizing Measurement of Social and Behavioral Dimensions of Cancer Prevention and Control to Enhance Outreach and Engagement in NCI-Designated Cancer Centers. (PubMed)

Standardizing Measurement of Social and Behavioral Dimensions of Cancer Prevention and Control to Enhance Outreach and Engagement in NCI-Designated Cancer Centers. 30670459 2019 03 08 1538-7755 28 3 2019 Mar Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology Cancer Epidemiol. Biomarkers Prev. Standardizing Measurement of Social and Behavioral Dimensions of Cancer Prevention (...) and Control to Enhance Outreach and Engagement in NCI-Designated Cancer Centers. 431-434 10.1158/1055-9965.EPI-18-0794 Gage-Bouchard Elizabeth A EA Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York. Elizabeth.bouchard@roswellpark.org. Rawl Susan M SM https://orcid.org/0000-0003-2052-2853 Simon Cancer Center, Indiana University, Indianapolis, Indiana. eng P30 CA016056 CA NCI NIH HHS United States P30 CA082709 CA NCI NIH HHS United States Editorial 2019

2019 Cancer Epidemiology & Biomarkers and Prevention

63. Maximizing research impacts on cancer prevention: An integrated knowledge translation approach used by the Canadian Population Attributable Risk of Cancer (ComPARe) study. (PubMed)

Maximizing research impacts on cancer prevention: An integrated knowledge translation approach used by the Canadian Population Attributable Risk of Cancer (ComPARe) study. With a strong focus on end user, or knowledge user, engagement throughout the study, an integrated knowledge translation approach (iKT) is expected to enhance the quality, relevance and reach of research findings. From its initiation, the Canadian Population Attributable Risk of Cancer (ComPARe) study combined the expertise (...) of the knowledge producers (cancer prevention researchers) and select knowledge users in an iKT approach. We describe in detail our iKT approach, including governance, outputs and early reflections. In our model, knowledge users were integrated as members of the research team or members of a KT Advisory Committee. The integrated knowledge users took a lead role on the KT activities for ComPARe, including developing the KT Blueprint, a four phase systematic approach to guide the planning and implementation

2019 Preventive Medicine

64. Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study. (PubMed)

Risk factors for cancer-associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE-PACC) study. The Khorana Score is a validated risk score for predicting 6-month incidence of cancer-associated venous thromboembolism (CAT) among patients starting chemotherapy. Venous thromboembolism (VTE) risk factors important in the general population, including age, sex, prior VTE, and hospitalization, are not included in this score, their association (...) with VTE in cancer patients is unknown.To examine risk factors for CAT and the impact of incorporating longitudinal hospitalization into risk assessment.Risk factors were recorded among patients starting chemotherapy at a single institution from 2012-14. Hospitalization and time-periods after hospitalization were assessed as time-varying covariates. Logistic regression was used to determine factors related to 6-month CAT risk (the Khorana Score endpoint). Proportional hazard models were used for risk

2019 Journal of Thrombosis and Haemostasis

65. Common osteoporosis drugs may prevent breast cancer spreading to bone

Common osteoporosis drugs may prevent breast cancer spreading to bone Common osteoporosis drugs may prevent breast cancer spreading to bone Discover Portal Discover Portal Common osteoporosis drugs may prevent breast cancer spreading to bone Published on 13 March 2018 doi: Drugs commonly prescribed to prevent bone thinning probably help prevent the spread of early breast cancer to the bones in a few women, when taken in addition to standard cancer therapies. However, the overall benefits may (...) be small, for example preventing spread to bone or death in about one extra woman in every 100 treated for about five years. This is a complex area because many of the treatments for breast cancer are known to worsen bone thinning, but there are other bone strengthening benefits to these drugs. This large review of 44 studies with more than 37,000 participants looked at women with either early breast cancer or advanced breast cancer with or without bone involvement. The reviewers also concluded

2018 NIHR Dissemination Centre

66. Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes

Prevention and Screening in BRCA Mutation Carriers and Other Breast/Ovarian Hereditary Cancer Syndromes PreventionandscreeninginBRCAmutationcarriersand otherbreast/ovarianhereditarycancersyndromes: ESMOClinicalPracticeGuidelinesforcancerprevention andscreening † S.Paluch-Shimon 1 ,F.Cardoso 2 ,C.Sessa 3 ,J.Balmana 4 ,M.J.Cardoso 2 ,F.Gilbert 5 &E.Senkus 6 , onbehalfoftheESMOGuidelinesCommittee * 1 DivisionofOncologyandtheDrPinchasBorensteinTalpiotMedicalLeadershipProgram,ShebaMedicalCenter (...) ,RamatGan,Israel; 2 BreastUnit,ChampalimaudClinical Center,Lisbon,Portugal; 3 OncologyInstituteofSouthernSwitzerland,OspedaleSanGiovanni,Bellinzona,Switzerland; 4 Valld`HebronUniversityHospitalInstitut d’Oncologia,Barcelona,Spain; 5 SchoolofClinicalMedicine,UniversityofCambridge,Cambridge,UK; 6 DepartmentofOncologyandRadiotherapy,MedicalUniversityof Gdan ´sk,Gdan ´sk,Poland The guidelines will focus on cancer prevention and screening among individuals known to harbour a pathogenic BRCA1/2 mutation

2017 European Society for Medical Oncology

67. Colorectal Cancer Prevention: Lifestyle

Colorectal Cancer Prevention: Lifestyle Colorectal cancer prevention: lifestyle | ACPGBI Toggle navigation Toggle site search Search the ACPGBI website Submit Case reports, procedural guidelines, good practice, conference presentations, videos, e-publications and more, searchable by specialism and audience. Upcoming and future colorectal conferences, courses, workshops and meetings, searchable by location, specialism and audience. Keep up-to-date on campaigns, publications, research (...) and training, plus announcements and annual meeting news. > > > Colorectal cancer prevention: lifestyle Colorectal cancer prevention: lifestyle Annie Anderson's presentation at the 2016 ACPGBI Annual Meeting This guide is designed to support clinical teams, commissioners, employers and managers to understand and evaluate the contribution of CNSs in cancer as they plan their local workforce and service improvement strategies Tagged with: Please enable JavaScript to view the Registered office: Royal College

2017 Association of Coloproctology of Great Britain and Ireland

68. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients We use cookies to enhance your experience on our website. By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting (...) in advanced cancer patients | Annals of Oncology | Oxford Academic Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article navigation September 2016 Article Contents Article Navigation 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients F. Roila 1Medical Oncology, Santa Maria

Full Text available with Trip Pro

2016 International Society for Oral Oncology

69. Oral cryotherapy: preventing mouth soreness and ulcers in people having cancer treatments

Oral cryotherapy: preventing mouth soreness and ulcers in people having cancer treatments Oral cryotherapy: preventing mouth soreness and ulcers in people having cancer treatments - Evidently Cochrane Search and hit Go By January 15, 2016 // Oral mucositis is a common side effect of high-dose chemotherapy: can cryotherapy help? It’s a long time since I worked on a children’s cancer ward, but I do remember that sore mouths were a miserable problem for many and that we did several things to help (...) prevent ulceration, including giving the children ice chips to suck. So I was interested to see a brand new Cochrane review investigating whether making the mouth cold (with ice, iced water, ice cream or ice lollies) is effective in preventing ulceration in people having cancer treatments. Properly termed oral cryotherapy, it’s free, it’s simple, it’s natural, but does it work? It would be good to know. It’s not just a sore mouth Oral mucositis is a common side effect of high-dose chemotherapy

2016 Evidently Cochrane

70. Cervical Cancer Screening and Prevention

Cervical Cancer Screening and Prevention Sign In (ACOG) Sign in to your ACOG account Email is required. Please enter valid Email. was not found in our system. Would you like to associated with your account? Forgot your email address? JSOG Member? © 2019 - American College of Obstetricians and Gynecologists

2016 American College of Obstetricians and Gynecologists

71. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers

Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline | Journal of Clinical Oncology Search in: Menu Article Tools ASCO SPECIAL ARTICLE Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2016.70.5400 Journal of Clinical Oncology - published online before print December 5 (...) , 2016 PMID: Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline x Saro H. Armenian , x Christina Lacchetti , x Ana Barac , x Joseph Carver , x Louis S. Constine , x Neelima Denduluri , x Susan Dent , x Pamela S. Douglas , x Jean-Bernard Durand , x Michael Ewer , x Carol Fabian , x Melissa Hudson , x Mariell Jessup , x Lee W. Jones , x Bonnie Ky , x Erica L. Mayer , x Javid Moslehi , x Kevin Oeffinger , x

2016 American Society of Clinical Oncology Guidelines

72. Secondary Prevention of Cervical Cancer Resource-Stratified Guideline

Secondary Prevention of Cervical Cancer Resource-Stratified Guideline Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Clinical Practice Guideline | Journal of Global Oncology Search in: Menu Article Tools SPECIAL ARTICLES Article Tools OPTIONS & TOOLS COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JGO.2016.006577 Journal of Global Oncology - published online before print October 12, 2016 PMID: Secondary Prevention of Cervical Cancer: ASCO Resource (...) : Purpose To provide resource-stratified, evidence-based recommendations on the secondary prevention of cervical cancer globally. Methods ASCO convened a multidisciplinary, multinational panel of oncology, primary care, epidemiology, health economic, cancer control, public health, and patient advocacy experts to produce recommendations reflecting four resource-tiered settings. A review of existing guidelines, a formal consensus-based process, and a modified ADAPTE process to adapt existing guidelines

2016 American Society of Clinical Oncology Guidelines

73. Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication

Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication Final Update Summary: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication - US Preventive Services Task Force Search USPSTF Website Text size: Assembly version: 1.0.0.308 Last Build: 11/16/2018 6:27:19 PM You are here: Final Summary Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication Release Date: February 2014 Recommendation Summary Summary of Recommendations and Evidence (...) Population Recommendation Grade Use of Multivitamins to Prevent Cardiovascular Disease or Cancer The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of multivitamins for the prevention of cardiovascular disease or cancer. Single- or Paired-Nutrient Supplements for Prevention of Cardiovascular Disease or Cancer The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the use of single

2014 U.S. Preventive Services Task Force

74. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force

Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the US Preventive Services Task Force Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the US (...) Preventive Services Task Force Fortmann SP, Burda BU, Senger CA, Lin JS, Whitlock EP CRD summary This review concluded that evidence for an effect of nutritional doses on cardiovascular disease, cancer, or mortality in healthy individuals without nutritional deficiencies was limited. In most cases there were insufficient data to draw any conclusion but for vitamin E and beta-carotene a lack of benefit was consistent across several trials. This conclusion is likely to be reliable. Authors' objectives

Full Text available with Trip Pro

2013 DARE.

75. The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines (PubMed)

The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines 30084718 2019 03 04 2378-9506 4 2018 Jul Journal of global oncology J Glob Oncol The Role of Humanitarian Donations in Decreasing Preventable Mortality From Cancer in Low-Income Countries: Models to Improve Access to Life-Saving Medicines. 1-3 10.1200/JGO.18.00096 Garcia-Gonzalez Pat P Pat Garcia-Gonzalez and Erin Schwartz, The Max (...) Foundation, Seattle, WA; Gilberto Lopes, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA. Lopes Gilberto G Pat Garcia-Gonzalez and Erin Schwartz, The Max Foundation, Seattle, WA; Gilberto Lopes, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Lawrence N. Shulman, University of Pennsylvania, Philadelphia, PA. Schwartz Erin E Pat Garcia-Gonzalez and Erin Schwartz, The Max Foundation

Full Text available with Trip Pro

2018 Journal of global oncology

76. Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention (PubMed)

Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention Patients with bladder cancer are at high risk of developing both venous and arterial thromboembolic events. Factors that contribute to this phenomenon include the hypercoagulable state induced by the malignancy itself, medical comorbidities that are common in this predominantly elderly patient population as well as treatments such as prolonged pelvic surgery and cisplatin-based chemotherapy. While formal (...) guidelines address prevention of venous thromboembolism in patients undergoing radical cystectomy, consensus regarding the role of pharmacologic prophylaxis in patients with bladder cancer being treated with chemotherapy, either with neoadjuvant or adjuvant intent in conjunction with radical cystectomy, as part of bladder preservation protocols or for metastatic disease, has proved elusive. The present narrative review was undertaken to define the incidence of and identify risk factors

Full Text available with Trip Pro

2018 Bladder cancer (Amsterdam, Netherlands)

77. Breast Cancer Prevention: Current Approaches and Future Directions (PubMed)

Breast Cancer Prevention: Current Approaches and Future Directions The topic of breast cancer prevention is very broad. All aspects of the topic, therefore, cannot be adequately covered in a single review. The objective of this review is to discuss strategies in current use to prevent breast cancer, as well as potential approaches that could be used in the future. This review does not discuss early detection strategies for breast cancer, including breast cancer screening. The breast is the most (...) common site among women worldwide of noncutaneous cancer. Many clinical and genetic factors have been found to increase a woman's risk of developing the disease. Current strategies to decrease a woman's risk of developing breast cancer include primary prevention, such as avoiding tobacco, exogenous hormone use and excess exposure to ionizing radiation, maintaining a normal weight, exercise, breastfeeding, eating a healthy diet and minimizing alcohol intake. Chemoprevention medications are available

Full Text available with Trip Pro

2018 European journal of breast health

78. Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? (PubMed)

Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? Purpose There remains considerable international variation in breast cancer incidence and mortality, but a comprehensive examination of rates by country level economic, development and cancer prevention policies is lacking. Materials and Methods We compared GLOBOCAN 2012 age-specific breast cancer incidence and mortality rates for 177 countries by using (...) ; economic development indicators additionally increased this percentage by approximately 4%. Country-level cancer prevention policy indicators contributed little to explanation of the overall variation in incidence and mortality after analysis accounted for age and country-level income; however, an overall resource summary index of greater economic development and cancer prevention policies was related to lower mortality within each major income level. Conclusion Although breast cancer incidence

Full Text available with Trip Pro

2018 Journal of global oncology

79. CDC Activities to Enhance Training in Cancer Prevention and Control in Field Epidemiology Training Programs in Low- and Middle-Income Countries (PubMed)

CDC Activities to Enhance Training in Cancer Prevention and Control in Field Epidemiology Training Programs in Low- and Middle-Income Countries Cancer is one of the leading causes of morbidity and mortality worldwide. In 2012, there were > 14 million new cancer cases and > 8 million cancer deaths, with 70% of these deaths occurring in low- and middle-income countries (LMICs). Part of the success of cancer prevention and control efforts requires the development and strengthening of the public (...) health workforce, particularly in LMICs where the cancer burden is the greatest. The US Centers for Disease Control and Prevention (CDC) supports workforce capacity development globally through Field Epidemiology Training Programs (FETPs) established in ministries of health in > 70 countries. To enhance training in cancer prevention and control in FETPs, the CDC has developed an open-access curriculum in applied cancer epidemiology and supports FETP trainees who conduct cancer-related planned

Full Text available with Trip Pro

2018 Journal of global oncology

80. Skin cancer knowledge, attitudes, beliefs, and prevention practices among medical students: A systematic search and literature review (PubMed)

Skin cancer knowledge, attitudes, beliefs, and prevention practices among medical students: A systematic search and literature review As future physicians, medical students will play an important role in the prevention of skin cancers by becoming directly involved in skin cancer prevention education and counseling patients about the hazards of ultraviolet light.We assessed the skin cancer-related knowledge, attitudes, beliefs, and prevention practices reported in previous studies of medical (...) . Important findings include moderate-to-high levels of skin cancer knowledge and low levels of both sunscreen and ultraviolet light knowledge. The attitudes and knowledge of medical students reflect a low level of concern with regard to the perceived importance of skin cancer compared with other forms of cancer despite a high level of concern for the importance of skin cancer prevention. Furthermore, this review demonstrated that medical students fail to protect themselves routinely from the sun and have

Full Text available with Trip Pro

2018 International journal of women's dermatology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>